Suven Life Sciences to incorporate overseas subsidiary

17 Aug 2015 Evaluate

Suven Life Sciences has received an approval to create an overseas subsidiary with an initial investment of $25 million for clinical development and commercialization of Suven pipeline and in-licensed molecules. The board of directors at their meeting held on August 14, 2015 has approved for the same.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.


Suven Life Sciences Share Price

166.80 3.75 (2.30%)
30-Dec-2025 11:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.15
Dr. Reddys Lab 1268.00
Cipla 1489.20
Zydus Lifesciences 901.60
Lupin 2073.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×